Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL
BONE MARROW TRANSPLANTATION
Giebel, S; Stella-Holowiecka, B; Krawczyk-Kulis, M; Gokbuget, N; Hoelzer, D; Doubek, M; Mayer, J; Piatkowska-Jakubas, B; Skotnicki, AB; Dombret, H; Ribera, JM; Piccaluga, PP; Czerw, T; Kyrcz-Krzemien, S; Holowiecki, J, 2010: Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL. BONE MARROW TRANSPLANTATION 45(6), p. 1095 - 1101, doi: 10.1038/bmt.2009.308
CEITEC authors: